CIDRAP newsletters options
Another mpox study today showed that dose-sparing vaccine administration of the Jynneos vaccine appeared to have worked.
With vaccine uptake low, the CDC warns of an urgent need to increase vaccine coverage for flu, COVID-19, and RSV.
This age-group is at higher risk for severe RSV and death because of age-related immune-system weakening and a higher rate of underlying medical conditions.
The FDA says the products have not gone through the drug review process and are being sold over the counter illegally.
While the findings can't be extrapolated to humans, the research provides some insight into real-world transmission of resistant bacteria between hosts.
The additional doses are on top of 77,000 made available in November.
Deaths are at the country's highest level in 7 years.
Cases have been reported in 23 states, including 1 death in Wisconsin.
The most common long-COVID symptoms were fatigue, cognitive impairment, and pain.
Multiple factors are fueling rises and compounding the impact, including shifts in dengue serotypes.
Being a female GP treating COVID patients was linked to a 54% higher risk of exhaustion compared with their male counterparts.
No long COVID was reported among vaccinated athletes.
The study authors say the findings add to evidence from prior studies, which have found limited improved clinical outcomes with combination therapy.
Researchers say new cleaning and disinfection methods that can better eradicate C difficile spores could help reduce the risk of healthcare transmission.
Current vaccines neutralize current variants, but there are limited data on the impact against JN.1, a steadily rising part of the BA.2.86 family.
Flu levels continue to climb in North America, as well as other locations including China's northern provinces.
In the COVID-19 pandemic years 2020 to 2021, IPD incidence dipped to a low of 1.6 per 100,000 children.
Families headed by an adult with long COVID had higher odds of pandemic-related financial difficulties, regardless of prepandemic socioeconomic status.
The median time to symptom resolution was 6 days, and 12% of participants still had symptoms at day 10.
Black patients were more likely to be diagnosed later and wait longer to receive appropriate antibiotics.
